img

Global Nanotechnology-based Drug Delivery Systems Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Nanotechnology-based Drug Delivery Systems Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.
Global Nanotechnology-based Drug Delivery Systems market is projected to reach US$ 9857 million in 2029, increasing from US$ 5019 million in 2022, with the CAGR of 10.0% during the period of 2024 to 2029. Demand from Hospital and Retail Pharmacy are the major drivers for the industry.
The Nano-based Drug Delivery System Market is driven by the demand for more effective and targeted drug delivery methods. Nano-based systems offer improved drug solubility, bioavailability, and reduced side effects. However, a significant challenge is the complexity of nanotechnology and the need for rigorous safety assessments and regulatory approvals. Ensuring the safety and biocompatibility of nano-based drug delivery systems is crucial. Additionally, competition in the market and cost considerations pose challenges, necessitating a balance between affordability and the development of advanced nano-based drug delivery technologies to meet the evolving needs of the pharmaceutical industry while ensuring patient well-being.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nanotechnology-based Drug Delivery Systems market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Johnson & Johnson
Sun Pharmaceutical
CSPC
Kinyond
Teva
Fudan-Zhangjiang
Zydus Cadila
TTY Biopharma
Pacira
Luye Pharma
Leadiant Biosciences
Ipsen
Sayre Therapeutics
Jazz
Alnylam
Bausch Health
Acrotech Biopharma
Takeda
Chiesi Farmaceutici
Gilead Sciences
Segment by Type
Liposomes Drugs
Lipid Nanoparticle Drugs

Segment by Application


Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Nanotechnology-based Drug Delivery Systems market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Nanotechnology-based Drug Delivery Systems introduction, etc. Nanotechnology-based Drug Delivery Systems Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Nanotechnology-based Drug Delivery Systems market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Nanotechnology-based Drug Delivery Systems
1.1 Nanotechnology-based Drug Delivery Systems Market Overview
1.1.1 Nanotechnology-based Drug Delivery Systems Product Scope
1.1.2 Nanotechnology-based Drug Delivery Systems Market Status and Outlook
1.2 Global Nanotechnology-based Drug Delivery Systems Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Nanotechnology-based Drug Delivery Systems Market Size by Region (2018-2029)
1.4 Global Nanotechnology-based Drug Delivery Systems Historic Market Size by Region (2018-2024)
1.5 Global Nanotechnology-based Drug Delivery Systems Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Nanotechnology-based Drug Delivery Systems Market Size (2018-2029)
1.6.1 North America Nanotechnology-based Drug Delivery Systems Market Size (2018-2029)
1.6.2 Europe Nanotechnology-based Drug Delivery Systems Market Size (2018-2029)
1.6.3 Asia-Pacific Nanotechnology-based Drug Delivery Systems Market Size (2018-2029)
1.6.4 Latin America Nanotechnology-based Drug Delivery Systems Market Size (2018-2029)
1.6.5 Middle East & Africa Nanotechnology-based Drug Delivery Systems Market Size (2018-2029)
2 Nanotechnology-based Drug Delivery Systems Market by Type
2.1 Introduction
2.1.1 Liposomes Drugs
2.1.2 Lipid Nanoparticle Drugs
2.2 Global Nanotechnology-based Drug Delivery Systems Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Nanotechnology-based Drug Delivery Systems Historic Market Size by Type (2018-2024)
2.2.2 Global Nanotechnology-based Drug Delivery Systems Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Nanotechnology-based Drug Delivery Systems Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Nanotechnology-based Drug Delivery Systems Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Nanotechnology-based Drug Delivery Systems Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Nanotechnology-based Drug Delivery Systems Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Nanotechnology-based Drug Delivery Systems Revenue Breakdown by Type (2018-2029)
3 Nanotechnology-based Drug Delivery Systems Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Retail Pharmacy
3.1.3 Other
3.2 Global Nanotechnology-based Drug Delivery Systems Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Nanotechnology-based Drug Delivery Systems Historic Market Size by Application (2018-2024)
3.2.2 Global Nanotechnology-based Drug Delivery Systems Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Nanotechnology-based Drug Delivery Systems Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Nanotechnology-based Drug Delivery Systems Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Nanotechnology-based Drug Delivery Systems Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Nanotechnology-based Drug Delivery Systems Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Nanotechnology-based Drug Delivery Systems Revenue Breakdown by Application (2018-2029)
4 Nanotechnology-based Drug Delivery Systems Competition Analysis by Players
4.1 Global Nanotechnology-based Drug Delivery Systems Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nanotechnology-based Drug Delivery Systems as of 2022)
4.3 Date of Key Players Enter into Nanotechnology-based Drug Delivery Systems Market
4.4 Global Top Players Nanotechnology-based Drug Delivery Systems Headquarters and Area Served
4.5 Key Players Nanotechnology-based Drug Delivery Systems Product Solution and Service
4.6 Competitive Status
4.6.1 Nanotechnology-based Drug Delivery Systems Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Johnson & Johnson
5.1.1 Johnson & Johnson Profile
5.1.2 Johnson & Johnson Main Business
5.1.3 Johnson & Johnson Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
5.1.4 Johnson & Johnson Nanotechnology-based Drug Delivery Systems Revenue (US$ Million) & (2018-2024)
5.1.5 Johnson & Johnson Recent Developments
5.2 Sun Pharmaceutical
5.2.1 Sun Pharmaceutical Profile
5.2.2 Sun Pharmaceutical Main Business
5.2.3 Sun Pharmaceutical Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
5.2.4 Sun Pharmaceutical Nanotechnology-based Drug Delivery Systems Revenue (US$ Million) & (2018-2024)
5.2.5 Sun Pharmaceutical Recent Developments
5.3 CSPC
5.3.1 CSPC Profile
5.3.2 CSPC Main Business
5.3.3 CSPC Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
5.3.4 CSPC Nanotechnology-based Drug Delivery Systems Revenue (US$ Million) & (2018-2024)
5.3.5 Kinyond Recent Developments
5.4 Kinyond
5.4.1 Kinyond Profile
5.4.2 Kinyond Main Business
5.4.3 Kinyond Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
5.4.4 Kinyond Nanotechnology-based Drug Delivery Systems Revenue (US$ Million) & (2018-2024)
5.4.5 Kinyond Recent Developments
5.5 Teva
5.5.1 Teva Profile
5.5.2 Teva Main Business
5.5.3 Teva Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
5.5.4 Teva Nanotechnology-based Drug Delivery Systems Revenue (US$ Million) & (2018-2024)
5.5.5 Teva Recent Developments
5.6 Fudan-Zhangjiang
5.6.1 Fudan-Zhangjiang Profile
5.6.2 Fudan-Zhangjiang Main Business
5.6.3 Fudan-Zhangjiang Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
5.6.4 Fudan-Zhangjiang Nanotechnology-based Drug Delivery Systems Revenue (US$ Million) & (2018-2024)
5.6.5 Fudan-Zhangjiang Recent Developments
5.7 Zydus Cadila
5.7.1 Zydus Cadila Profile
5.7.2 Zydus Cadila Main Business
5.7.3 Zydus Cadila Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
5.7.4 Zydus Cadila Nanotechnology-based Drug Delivery Systems Revenue (US$ Million) & (2018-2024)
5.7.5 Zydus Cadila Recent Developments
5.8 TTY Biopharma
5.8.1 TTY Biopharma Profile
5.8.2 TTY Biopharma Main Business
5.8.3 TTY Biopharma Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
5.8.4 TTY Biopharma Nanotechnology-based Drug Delivery Systems Revenue (US$ Million) & (2018-2024)
5.8.5 TTY Biopharma Recent Developments
5.9 Pacira
5.9.1 Pacira Profile
5.9.2 Pacira Main Business
5.9.3 Pacira Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
5.9.4 Pacira Nanotechnology-based Drug Delivery Systems Revenue (US$ Million) & (2018-2024)
5.9.5 Pacira Recent Developments
5.10 Luye Pharma
5.10.1 Luye Pharma Profile
5.10.2 Luye Pharma Main Business
5.10.3 Luye Pharma Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
5.10.4 Luye Pharma Nanotechnology-based Drug Delivery Systems Revenue (US$ Million) & (2018-2024)
5.10.5 Luye Pharma Recent Developments
5.11 Leadiant Biosciences
5.11.1 Leadiant Biosciences Profile
5.11.2 Leadiant Biosciences Main Business
5.11.3 Leadiant Biosciences Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
5.11.4 Leadiant Biosciences Nanotechnology-based Drug Delivery Systems Revenue (US$ Million) & (2018-2024)
5.11.5 Leadiant Biosciences Recent Developments
5.12 Ipsen
5.12.1 Ipsen Profile
5.12.2 Ipsen Main Business
5.12.3 Ipsen Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
5.12.4 Ipsen Nanotechnology-based Drug Delivery Systems Revenue (US$ Million) & (2018-2024)
5.12.5 Ipsen Recent Developments
5.13 Sayre Therapeutics
5.13.1 Sayre Therapeutics Profile
5.13.2 Sayre Therapeutics Main Business
5.13.3 Sayre Therapeutics Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
5.13.4 Sayre Therapeutics Nanotechnology-based Drug Delivery Systems Revenue (US$ Million) & (2018-2024)
5.13.5 Sayre Therapeutics Recent Developments
5.14 Jazz
5.14.1 Jazz Profile
5.14.2 Jazz Main Business
5.14.3 Jazz Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
5.14.4 Jazz Nanotechnology-based Drug Delivery Systems Revenue (US$ Million) & (2018-2024)
5.14.5 Jazz Recent Developments
5.15 Alnylam
5.15.1 Alnylam Profile
5.15.2 Alnylam Main Business
5.15.3 Alnylam Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
5.15.4 Alnylam Nanotechnology-based Drug Delivery Systems Revenue (US$ Million) & (2018-2024)
5.15.5 Alnylam Recent Developments
5.16 Bausch Health
5.16.1 Bausch Health Profile
5.16.2 Bausch Health Main Business
5.16.3 Bausch Health Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
5.16.4 Bausch Health Nanotechnology-based Drug Delivery Systems Revenue (US$ Million) & (2018-2024)
5.16.5 Bausch Health Recent Developments
5.17 Acrotech Biopharma
5.17.1 Acrotech Biopharma Profile
5.17.2 Acrotech Biopharma Main Business
5.17.3 Acrotech Biopharma Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
5.17.4 Acrotech Biopharma Nanotechnology-based Drug Delivery Systems Revenue (US$ Million) & (2018-2024)
5.17.5 Acrotech Biopharma Recent Developments
5.18 Takeda
5.18.1 Takeda Profile
5.18.2 Takeda Main Business
5.18.3 Takeda Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
5.18.4 Takeda Nanotechnology-based Drug Delivery Systems Revenue (US$ Million) & (2018-2024)
5.18.5 Takeda Recent Developments
5.19 Chiesi Farmaceutici
5.19.1 Chiesi Farmaceutici Profile
5.19.2 Chiesi Farmaceutici Main Business
5.19.3 Chiesi Farmaceutici Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
5.19.4 Chiesi Farmaceutici Nanotechnology-based Drug Delivery Systems Revenue (US$ Million) & (2018-2024)
5.19.5 Chiesi Farmaceutici Recent Developments
5.20 Gilead Sciences
5.20.1 Gilead Sciences Profile
5.20.2 Gilead Sciences Main Business
5.20.3 Gilead Sciences Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
5.20.4 Gilead Sciences Nanotechnology-based Drug Delivery Systems Revenue (US$ Million) & (2018-2024)
5.20.5 Gilead Sciences Recent Developments
6 North America
6.1 North America Nanotechnology-based Drug Delivery Systems Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Nanotechnology-based Drug Delivery Systems Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Nanotechnology-based Drug Delivery Systems Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Nanotechnology-based Drug Delivery Systems Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Nanotechnology-based Drug Delivery Systems Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Nanotechnology-based Drug Delivery Systems Market Dynamics
11.1 Nanotechnology-based Drug Delivery Systems Industry Trends
11.2 Nanotechnology-based Drug Delivery Systems Market Drivers
11.3 Nanotechnology-based Drug Delivery Systems Market Challenges
11.4 Nanotechnology-based Drug Delivery Systems Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Nanotechnology-based Drug Delivery Systems Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Nanotechnology-based Drug Delivery Systems Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Nanotechnology-based Drug Delivery Systems Market Size Share by Region (2018-2024)
Table 4. Global Nanotechnology-based Drug Delivery Systems Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Nanotechnology-based Drug Delivery Systems Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Nanotechnology-based Drug Delivery Systems Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Nanotechnology-based Drug Delivery Systems Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Nanotechnology-based Drug Delivery Systems Revenue Market Share by Type (2018-2024)
Table 9. Global Nanotechnology-based Drug Delivery Systems Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Nanotechnology-based Drug Delivery Systems Revenue Market Share by Type (2024-2029)
Table 11. North America Nanotechnology-based Drug Delivery Systems Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Nanotechnology-based Drug Delivery Systems Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Nanotechnology-based Drug Delivery Systems Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Nanotechnology-based Drug Delivery Systems Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Nanotechnology-based Drug Delivery Systems Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Nanotechnology-based Drug Delivery Systems Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Nanotechnology-based Drug Delivery Systems Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Nanotechnology-based Drug Delivery Systems Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Nanotechnology-based Drug Delivery Systems Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Nanotechnology-based Drug Delivery Systems Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Nanotechnology-based Drug Delivery Systems Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Nanotechnology-based Drug Delivery Systems Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Nanotechnology-based Drug Delivery Systems Revenue Market Share by Application (2018-2024)
Table 24. Global Nanotechnology-based Drug Delivery Systems Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Nanotechnology-based Drug Delivery Systems Revenue Market Share by Application (2024-2029)
Table 26. North America Nanotechnology-based Drug Delivery Systems Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Nanotechnology-based Drug Delivery Systems Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Nanotechnology-based Drug Delivery Systems Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Nanotechnology-based Drug Delivery Systems Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Nanotechnology-based Drug Delivery Systems Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Nanotechnology-based Drug Delivery Systems Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Nanotechnology-based Drug Delivery Systems Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Nanotechnology-based Drug Delivery Systems Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Nanotechnology-based Drug Delivery Systems Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Nanotechnology-based Drug Delivery Systems Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Nanotechnology-based Drug Delivery Systems Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Nanotechnology-based Drug Delivery Systems Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nanotechnology-based Drug Delivery Systems as of 2022)
Table 39. Date of Key Players Enter into Nanotechnology-based Drug Delivery Systems Market
Table 40. Global Nanotechnology-based Drug Delivery Systems Key Players Headquarters and Area Served
Table 41. Nanotechnology-based Drug Delivery Systems Product Solution and Service
Table 42. Global Nanotechnology-based Drug Delivery Systems Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Johnson & Johnson Basic Information List
Table 45. Johnson & Johnson Description and Business Overview
Table 46. Johnson & Johnson Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
Table 47. Revenue (US$ Million) in Nanotechnology-based Drug Delivery Systems Business of Johnson & Johnson (2018-2024)
Table 48. Johnson & Johnson Recent Developments
Table 49. Sun Pharmaceutical Basic Information List
Table 50. Sun Pharmaceutical Description and Business Overview
Table 51. Sun Pharmaceutical Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
Table 52. Revenue (US$ Million) in Nanotechnology-based Drug Delivery Systems Business of Sun Pharmaceutical (2018-2024)
Table 53. Sun Pharmaceutical Recent Developments
Table 54. CSPC Basic Information List
Table 55. CSPC Description and Business Overview
Table 56. CSPC Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
Table 57. Revenue (US$ Million) in Nanotechnology-based Drug Delivery Systems Business of CSPC (2018-2024)
Table 58. CSPC Recent Developments
Table 59. Kinyond Basic Information List
Table 60. Kinyond Description and Business Overview
Table 61. Kinyond Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
Table 62. Revenue (US$ Million) in Nanotechnology-based Drug Delivery Systems Business of Kinyond (2018-2024)
Table 63. Kinyond Recent Developments
Table 64. Teva Basic Information List
Table 65. Teva Description and Business Overview
Table 66. Teva Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
Table 67. Revenue (US$ Million) in Nanotechnology-based Drug Delivery Systems Business of Teva (2018-2024)
Table 68. Teva Recent Developments
Table 69. Fudan-Zhangjiang Basic Information List
Table 70. Fudan-Zhangjiang Description and Business Overview
Table 71. Fudan-Zhangjiang Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
Table 72. Revenue (US$ Million) in Nanotechnology-based Drug Delivery Systems Business of Fudan-Zhangjiang (2018-2024)
Table 73. Fudan-Zhangjiang Recent Developments
Table 74. Zydus Cadila Basic Information List
Table 75. Zydus Cadila Description and Business Overview
Table 76. Zydus Cadila Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
Table 77. Revenue (US$ Million) in Nanotechnology-based Drug Delivery Systems Business of Zydus Cadila (2018-2024)
Table 78. Zydus Cadila Recent Developments
Table 79. TTY Biopharma Basic Information List
Table 80. TTY Biopharma Description and Business Overview
Table 81. TTY Biopharma Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
Table 82. Revenue (US$ Million) in Nanotechnology-based Drug Delivery Systems Business of TTY Biopharma (2018-2024)
Table 83. TTY Biopharma Recent Developments
Table 84. Pacira Basic Information List
Table 85. Pacira Description and Business Overview
Table 86. Pacira Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
Table 87. Revenue (US$ Million) in Nanotechnology-based Drug Delivery Systems Business of Pacira (2018-2024)
Table 88. Pacira Recent Developments
Table 89. Luye Pharma Basic Information List
Table 90. Luye Pharma Description and Business Overview
Table 91. Luye Pharma Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
Table 92. Revenue (US$ Million) in Nanotechnology-based Drug Delivery Systems Business of Luye Pharma (2018-2024)
Table 93. Luye Pharma Recent Developments
Table 94. Leadiant Biosciences Basic Information List
Table 95. Leadiant Biosciences Description and Business Overview
Table 96. Leadiant Biosciences Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
Table 97. Revenue (US$ Million) in Nanotechnology-based Drug Delivery Systems Business of Leadiant Biosciences (2018-2024)
Table 98. Leadiant Biosciences Recent Developments
Table 99. Ipsen Basic Information List
Table 100. Ipsen Description and Business Overview
Table 101. Ipsen Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
Table 102. Revenue (US$ Million) in Nanotechnology-based Drug Delivery Systems Business of Ipsen (2018-2024)
Table 103. Ipsen Recent Developments
Table 104. Sayre Therapeutics Basic Information List
Table 105. Sayre Therapeutics Description and Business Overview
Table 106. Sayre Therapeutics Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
Table 107. Revenue (US$ Million) in Nanotechnology-based Drug Delivery Systems Business of Sayre Therapeutics (2018-2024)
Table 108. Sayre Therapeutics Recent Developments
Table 109. Jazz Basic Information List
Table 110. Jazz Description and Business Overview
Table 111. Jazz Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
Table 112. Revenue (US$ Million) in Nanotechnology-based Drug Delivery Systems Business of Jazz (2018-2024)
Table 113. Jazz Recent Developments
Table 114. Alnylam Basic Information List
Table 115. Alnylam Description and Business Overview
Table 116. Alnylam Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
Table 117. Revenue (US$ Million) in Nanotechnology-based Drug Delivery Systems Business of Alnylam (2018-2024)
Table 118. Alnylam Recent Developments
Table 119. Bausch Health Basic Information List
Table 120. Bausch Health Description and Business Overview
Table 121. Bausch Health Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
Table 122. Revenue (US$ Million) in Nanotechnology-based Drug Delivery Systems Business of Bausch Health (2018-2024)
Table 123. Bausch Health Recent Developments
Table 124. Acrotech Biopharma Basic Information List
Table 125. Acrotech Biopharma Description and Business Overview
Table 126. Acrotech Biopharma Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
Table 127. Revenue (US$ Million) in Nanotechnology-based Drug Delivery Systems Business of Acrotech Biopharma (2018-2024)
Table 128. Acrotech Biopharma Recent Developments
Table 129. Takeda Basic Information List
Table 130. Takeda Description and Business Overview
Table 131. Takeda Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
Table 132. Revenue (US$ Million) in Nanotechnology-based Drug Delivery Systems Business of Takeda (2018-2024)
Table 133. Takeda Recent Developments
Table 134. Chiesi Farmaceutici Basic Information List
Table 135. Chiesi Farmaceutici Description and Business Overview
Table 136. Chiesi Farmaceutici Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
Table 137. Revenue (US$ Million) in Nanotechnology-based Drug Delivery Systems Business of Chiesi Farmaceutici (2018-2024)
Table 138. Chiesi Farmaceutici Recent Developments
Table 139. Gilead Sciences Basic Information List
Table 140. Gilead Sciences Description and Business Overview
Table 141. Gilead Sciences Nanotechnology-based Drug Delivery Systems Products, Services and Solutions
Table 142. Revenue (US$ Million) in Nanotechnology-based Drug Delivery Systems Business of Gilead Sciences (2018-2024)
Table 143. Gilead Sciences Recent Developments
Table 144. North America Nanotechnology-based Drug Delivery Systems Market Size by Country (2018-2024) & (US$ Million)
Table 145. North America Nanotechnology-based Drug Delivery Systems Market Size by Country (2024-2029) & (US$ Million)
Table 146. Europe Nanotechnology-based Drug Delivery Systems Market Size by Country (2018-2024) & (US$ Million)
Table 147. Europe Nanotechnology-based Drug Delivery Systems Market Size by Country (2024-2029) & (US$ Million)
Table 148. Asia-Pacific Nanotechnology-based Drug Delivery Systems Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 149. Asia-Pacific Nanotechnology-based Drug Delivery Systems Market Size by Region (2018-2024) & (US$ Million)
Table 150. Asia-Pacific Nanotechnology-based Drug Delivery Systems Market Size by Region (2024-2029) & (US$ Million)
Table 151. Asia-Pacific Nanotechnology-based Drug Delivery Systems Market Share by Region (2018-2024)
Table 152. Asia-Pacific Nanotechnology-based Drug Delivery Systems Market Share by Region (2024-2029)
Table 153. Latin America Nanotechnology-based Drug Delivery Systems Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 154. Latin America Nanotechnology-based Drug Delivery Systems Market Size by Country (2018-2024) & (US$ Million)
Table 155. Latin America Nanotechnology-based Drug Delivery Systems Market Size by Country (2024-2029) & (US$ Million)
Table 156. Middle East & Africa Nanotechnology-based Drug Delivery Systems Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 157. Middle East & Africa Nanotechnology-based Drug Delivery Systems Market Size by Country (2018-2024) & (US$ Million)
Table 158. Middle East & Africa Nanotechnology-based Drug Delivery Systems Market Size by Country (2024-2029) & (US$ Million)
Table 159. Nanotechnology-based Drug Delivery Systems Market Trends
Table 160. Nanotechnology-based Drug Delivery Systems Market Drivers
Table 161. Nanotechnology-based Drug Delivery Systems Market Challenges
Table 162. Nanotechnology-based Drug Delivery Systems Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nanotechnology-based Drug Delivery Systems Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Nanotechnology-based Drug Delivery Systems Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Nanotechnology-based Drug Delivery Systems Market Share by Regions: 2022 VS 2029
Figure 4. Global Nanotechnology-based Drug Delivery Systems Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Nanotechnology-based Drug Delivery Systems Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Nanotechnology-based Drug Delivery Systems Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Nanotechnology-based Drug Delivery Systems Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Nanotechnology-based Drug Delivery Systems Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Nanotechnology-based Drug Delivery Systems Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Liposomes Drugs
Figure 11. Global Liposomes Drugs Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Lipid Nanoparticle Drugs
Figure 13. Global Lipid Nanoparticle Drugs Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Global Nanotechnology-based Drug Delivery Systems Market Size Share by Type: 2022 & 2029
Figure 15. North America Nanotechnology-based Drug Delivery Systems Revenue Market Share by Type (2018-2029)
Figure 16. Europe Nanotechnology-based Drug Delivery Systems Revenue Market Share by Type (2018-2029)
Figure 17. Asia-Pacific Nanotechnology-based Drug Delivery Systems Revenue Market Share by Type (2018-2029)
Figure 18. Latin America Nanotechnology-based Drug Delivery Systems Revenue Market Share by Type (2018-2029)
Figure 19. Middle East and Africa Nanotechnology-based Drug Delivery Systems Revenue Market Share by Type (2018-2029)
Figure 20. Hospital Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 21. Retail Pharmacy Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Other Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Global Nanotechnology-based Drug Delivery Systems Market Size Share by Application: 2022 & 2029
Figure 24. North America Nanotechnology-based Drug Delivery Systems Revenue Market Share by Application (2018-2029)
Figure 25. Europe Nanotechnology-based Drug Delivery Systems Revenue Market Share by Application (2018-2029)
Figure 26. Asia-Pacific Nanotechnology-based Drug Delivery Systems Revenue Market Share by Application (2018-2029)
Figure 27. Latin America Nanotechnology-based Drug Delivery Systems Revenue Market Share by Application (2018-2029)
Figure 28. Middle East and Africa Nanotechnology-based Drug Delivery Systems Revenue Market Share by Application (2018-2029)
Figure 29. Nanotechnology-based Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 30. Global Top 5 and Top 10 Players Nanotechnology-based Drug Delivery Systems Market Share in 2022
Figure 31. North America Nanotechnology-based Drug Delivery Systems Market Share by Country (2018-2029)
Figure 32. United States Nanotechnology-based Drug Delivery Systems Market Size (2018-2029) & (US$ Million)
Figure 33. Canada Nanotechnology-based Drug Delivery Systems Market Size (2018-2029) & (US$ Million)
Figure 34. Germany Nanotechnology-based Drug Delivery Systems Market Size (2018-2029) & (US$ Million)
Figure 35. France Nanotechnology-based Drug Delivery Systems Market Size (2018-2029) & (US$ Million)
Figure 36. U.K. Nanotechnology-based Drug Delivery Systems Market Size (2018-2029) & (US$ Million)
Figure 37. Italy Nanotechnology-based Drug Delivery Systems Market Size (2018-2029) & (US$ Million)
Figure 38. Russia Nanotechnology-based Drug Delivery Systems Market Size (2018-2029) & (US$ Million)
Figure 39. Nordic Countries Nanotechnology-based Drug Delivery Systems Market Size (2018-2029) & (US$ Million)
Figure 40. Asia-Pacific Nanotechnology-based Drug Delivery Systems Market Share by Region (2018-2029)
Figure 41. China Nanotechnology-based Drug Delivery Systems Market Size (2018-2029) & (US$ Million)
Figure 42. Japan Nanotechnology-based Drug Delivery Systems Market Size (2018-2029) & (US$ Million)
Figure 43. South Korea Nanotechnology-based Drug Delivery Systems Market Size (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Nanotechnology-based Drug Delivery Systems Market Size (2018-2029) & (US$ Million)
Figure 45. India Nanotechnology-based Drug Delivery Systems Market Size (2018-2029) & (US$ Million)
Figure 46. Australia Nanotechnology-based Drug Delivery Systems Market Size (2018-2029) & (US$ Million)
Figure 47. Latin America Nanotechnology-based Drug Delivery Systems Market Share by Country (2018-2029)
Figure 48. Mexico Nanotechnology-based Drug Delivery Systems Market Size (2018-2029) & (US$ Million)
Figure 49. Brazil Nanotechnology-based Drug Delivery Systems Market Size (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Nanotechnology-based Drug Delivery Systems Market Share by Country (2018-2029)
Figure 51. Turkey Nanotechnology-based Drug Delivery Systems Market Size (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Nanotechnology-based Drug Delivery Systems Market Size (2018-2029) & (US$ Million)
Figure 53. UAE Nanotechnology-based Drug Delivery Systems Market Size (2018-2029) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report